Depakote Cp

   
Google
 
Web NewDrugInformation.com

Depakote Cp


Drug - Depakote Cp
The trade name of the product as shown on the labeling.

Dosage - TABLET, DELAYED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Divalproex Sodium
Multiple ingredients are in alphabetical order.

Strength - EQ 500MG BASE
The potency of the active ingredient(s), Divalproex Sodium. May repeat for multiple part products.

Applicant - ABBOTT
The firm name holding legal responsibility for Depakote Cp. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019794
The FDA assigned number to Depakote Cp. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Depakote Cp. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 11, 1990
The date Depakote Cp was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Depakote Cp. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Depakote Cp is in. Format is RX, OTC, DISCN.

Applicant Full Name - Abbott Laboratories Pharmaceutical Products Div
The full name of the firm holding legal responsibility for the new application of Depakote Cp.

Depakote Cp